North Carolina Clinical Research

Executive Summary

North Carolina Clinical Research (NCCR) is a well-established, private clinical research site based in Raleigh, NC, with over 30 years of experience in conducting multi-therapeutic outpatient trials. Founded in 1994, the company has developed a strong reputation as a reliable bridge between pharmaceutical sponsors and patient volunteers, particularly in respiratory diseases such as asthma and COPD. NCCR's deep expertise in this therapeutic area positions it as a valuable partner for sponsors seeking efficient and high-quality trial execution in a concentrated patient population. While privately held and lacking public financial disclosures, NCCR's longevity and niche focus suggest stable operations and recurring business from repeat sponsors. Looking ahead, NCCR is likely to benefit from continued industry demand for respiratory clinical trials, driven by the growing prevalence of asthma and COPD globally. The company may also explore expansion into adjacent indications or leverage its site network to attract larger, more complex studies. However, as a small independent site, it faces competition from larger site management organizations and academic centers. Overall, NCCR represents a focused, experienced player in the clinical research ecosystem with moderate growth potential contingent on sustained sponsor relationships and trial awards.

Upcoming Catalysts (preview)

• Q2 2026Award of a major respiratory trial contract from a top-20 pharma65% success
• Q4 2026FDA decision on a COPD therapy for which NCCR contributed significant enrollment70% success
• TBDAnnouncement of capacity expansion or new therapeutic service line50% success